Group 1 - The core viewpoint of the news is that Sanbian Technology (SZ002112) experienced a limit-up on January 20, 2026, reaching a price of 24.17 yuan, with a 10.01% increase, and a total market capitalization of 7.109 billion yuan [1] - The company has established a subsidiary in Europe to expand its overseas market presence, which enhances its international competitiveness [1] - Sanbian Technology is diversifying its business by entering new fields such as electric vehicle charging infrastructure operations and energy storage technology services, which supports the recent stock price increase [1] Group 2 - The company's main business involves the research, production, and sales of various transformers, which are widely used in power systems, renewable energy, and data centers [1] - In January 2026, it was reported that some transformers were exported through foreign trade agents, including products sent to North America for data center construction, and the main transformer has entered Musk's X supercomputer center, attracting market attention [1] - The stock has been actively traded, with a total buy of 260 million yuan and a total sell of -140 million yuan on the leaderboard, indicating net buying from retail and institutional investors, which has driven the stock price to its limit-up [1]

Core Viewpoint - Baide International (02668.HK) has entered a memorandum of understanding with the major shareholder of a company established in Tanzania regarding a potential acquisition of part or all of the target company's equity, which includes an operational gold processing plant and gold exploration and production projects in Tanzania [1] Group 1 - The memorandum outlines that the company intends to conduct further due diligence on the target company and its assets, and negotiate transaction terms within a three-month period from the date of the memorandum [1] - The group is actively seeking to diversify its existing business and revenue sources through new business lines with significant growth potential to enhance shareholder value [1]

Group 1 - The company, Baide International (02668), has signed a memorandum of understanding with a major shareholder of a target company established in the United Republic of Tanzania for a potential acquisition of part or all of the target company's equity [1] - The target company operates a gold processing plant and is engaged in gold exploration and production projects in Tanzania [1] - The board of directors believes that the potential acquisition will provide an appropriate opportunity to expand the company's investment scope and diversify its revenue sources, thereby enhancing shareholder value [1] Group 2 - The memorandum includes plans for the company to conduct further due diligence on the target company and its assets, as well as negotiate transaction terms within a three-month period from the date of the memorandum [1] - The company has confirmed that, apart from one of the ultimate beneficial owners of the potential seller being the spouse of an independent non-executive director, the target company and its beneficial owners are independent of the company and its related parties [1] - The company is actively seeking new business lines with significant growth potential to diversify its existing operations and revenue sources [1]

Core Viewpoint - The company, Baide International, has signed a memorandum of understanding to potentially acquire part or all of the shares of a target company in Tanzania, which operates a gold processing plant and is involved in gold exploration and production [1][2] Group 1 - The memorandum of understanding was established on January 19, 2026, between Baide International (as a potential buyer) and the main shareholders of the target company (potential seller) [1] - The target company is currently operating a gold processing facility and is engaged in gold exploration and production projects in Tanzania [1] - The company has conducted reasonable inquiries and confirmed that, apart from one of the potential seller's ultimate beneficial owners being the spouse of an independent non-executive director of the company, the target company and its shareholders are independent of Baide International and its related parties [1] Group 2 - The company is actively seeking to diversify its existing business lines through new ventures with significant growth potential to enhance shareholder value [2] - The board believes that the potential acquisition represents a suitable opportunity to expand the company's investment scope and diversify its revenue sources, benefiting both the company and its shareholders [2]

Core Viewpoint - Junshi Group (01412) anticipates a decrease in net profit attributable to shareholders for the fiscal year ending December 31, 2025, estimated between approximately HKD 55 million to HKD 65 million, compared to HKD 129 million for the fiscal year ending December 31, 2024 [1][2] Group 1 - The expected decline in profit is primarily due to a reduction in Original Equipment Manufacturer (OEM) sales revenue for the fiscal year 2025, attributed to a softening consumer sentiment in certain markets, leading to decreased demand from major OEM clients [1] - The gross margin for OEM sales has also declined, influenced by transitional impacts and related costs from the ongoing integration of production capacity in Vietnam aimed at further diversifying the supply chain [1] - Despite the decrease in OEM sales revenue, the company has experienced moderate growth in website sales revenue for the fiscal year 2025 [1] Group 2 - The board remains confident in the company's financial position, expecting to navigate current challenges and seize new opportunities through diversification strategies [2] - The company maintains an optimistic outlook for its collectible card production business and website sales, aiming to expand its operations by strengthening partnerships and broadening coverage in various market segments [2]

Core Viewpoint - The company is positioned as a leading traffic infrastructure asset management company in China, with a "buy" rating and a target price of HKD 5.73 [1] Group 1: Company Performance - The company has been optimizing its assets to strengthen its toll road business, expecting a revenue growth of 14.9% to CNY 2.099 billion in the first half of 2025, aided by the inclusion of the Pinglin Expressway in November 2024 [2] - The company has maintained stable and sustainable dividends since 2010, with annual dividends accounting for approximately 50% to 60% of net profit attributable to shareholders [2][3] - The company controls, holds stakes in, and manages 18 projects including highways, bridges, and terminals, totaling approximately 1,039.54 kilometers [3] Group 2: Industry Context - The highway industry in China has entered a mature phase, having completed over 70% of the mileage targets set in the National Comprehensive Transportation Network Planning Outline [3] - Despite a steady recovery in overall industry revenue post-pandemic, rising costs for new road construction may lead to future revenue shortfalls [3] - New policies, such as the revised toll road management regulations, are expected to encourage highway companies to engage in upgrades, acquisitions of quality mature assets, and diversification of their business [3] Group 3: Investment and Financing - The company has established a unique asset layout with advantageous regional locations and good operational efficiency [4] - Over the past five years, the company has incubated highway assets worth nearly CNY 25 billion, and successfully set up a REITs platform in 2021, indicating a well-structured financial development model [4] - The company can utilize various financing tools through its three-platform structure, which includes incubation, public listing, and public REITs, to lower its debt ratio and optimize its asset structure [4]

Core Viewpoint - Southwest Securities has initiated coverage on Yuexiu Transportation Infrastructure (01052), the first highway red-chip stock listed in Hong Kong, with a "Buy" rating and a target price of HKD 5.73, anticipating the company to become a leading transportation infrastructure asset management firm in China [1]. Group 1: Company Performance - The company is strengthening its toll road business through continuous asset optimization, with projected overall revenue growth of 14.9% to CNY 2.099 billion in the first half of 2025, aided by the inclusion of the Pinglin Expressway in November 2024 [2]. - The company has maintained a stable and sustainable dividend policy since 2010, distributing approximately 50% to 60% of net profit attributable to shareholders as dividends annually [2]. - As of 2025, the company expects a net profit attributable to shareholders to grow by 14.9% to CNY 361 million [3]. Group 2: Industry Context - The highway industry in China has entered a mature phase, having completed over 70% of the mileage targets set in the National Comprehensive Transportation Network Planning Outline, with overall industry revenue steadily recovering post-pandemic [4]. - The rising costs of new road construction may lead to a revenue gap, which could be addressed through policy iterations and business diversification, as new regulations are anticipated to break the original toll duration trends [4]. Group 3: Investment and Asset Management - The company has established a unique asset layout with significant regional advantages and operational efficiency, having incubated highway assets worth nearly CNY 25 billion over the past five years [5]. - The successful establishment of a REITs platform in 2021 marks the formation of a three-platform structure (incubation platform, listed company, public REITs), enabling the company to utilize diverse financing tools and channels to optimize its capital structure [5].

Core Viewpoint - The announcement indicates a strategic collaboration between China Dental Industry and Bio-Hui Biotechnology to enhance their business operations in the healthcare sector, particularly in the Greater Bay Area [1] Group 1: Strategic Collaboration - China Digital Health, a wholly-owned subsidiary of China Dental Industry, has signed a memorandum of understanding with Bio-Hui Biotechnology to establish a joint venture [1] - The joint venture aims to form qualified medical and biotechnology teams to promote clinical treatment services in hospitals within the Greater Bay Area [1] Group 2: Business Diversification - The board of directors believes that this memorandum marks a new phase for the group in entering the medical biotechnology field and provides opportunities for diversified business development [1] - Through this strategic partnership, the group aims to leverage its connections in the Greater Bay Area to broaden its revenue base and enhance overall competitiveness [1]

Core Viewpoint - The announcement indicates a strategic collaboration between China Oral Industry and BioHui Biotechnology to enhance their business operations in the medical biotechnology sector, marking a new phase for the company [1] Group 1: Strategic Collaboration - China Digital Health Group, a wholly-owned subsidiary of China Oral Industry, has signed a memorandum of understanding with BioHui Biotechnology to establish a joint venture [1] - The collaboration aims to form qualified medical and biotechnology teams to promote clinical treatment services in the Greater Bay Area hospitals [1] Group 2: Company Growth and Diversification - The board believes that this memorandum signifies a new stage for the company’s entry into the medical biotechnology field and presents opportunities for diversified business development [1] - Through the strategic partnership with BioHui, the company aims to leverage its connections in the Greater Bay Area to broaden its revenue base and enhance overall competitiveness [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公 告 全部或任何部分內容而產生或因依賴該等內容而引致的任何損失承擔任何責 任。 China Oral Industry Group Holdings Limited 中國口腔產業集團控股有限公司 （於開曼群島註冊成立的有限公司） （股份代號︰8406） 自願公告 諒解備忘錄 本 公 告 乃 中 國 口 腔 產 業 集 團 控 股 有 限 公 司（「本公司」，連 同 其 附 屬 公 司 統 稱「本 集 團」）自 願 刊 發，旨 在 向 本 公 司 股 東（「股 東」）及 潛 在 投 資 者 提 供 有 關 本 集 團 最 新 業 務 發 展 的 最 新 資 料。 諒解備忘錄 本 公 司 董 事（「董 事」）董 事 會（「董事會」）欣 然 宣 布，於 二 零 二 六 年 一 月 十 二 日，本 公 司 間 接 全 資 附 屬 公 司 中 國 數 字 健 康 集 團 有 限 公 司（「中國數字健康」）與 博 惠 生 技 股 份 有 ...